Indication:
U.S FDA APPROVED DRUGS FROM 01-01-08 TO 31-12-08
Drug name Indication Date of Approval
103. Hylan GF 20 injection(sysvisc) 31-03-08
(Addl indication)
For pain management in patients suffering
with osteoarthiritis of the knee,hip, shoulder
and ankle
New drugs approved For Marketing by Drug Controller General of India(DCGI )
during the period January 1988 to November 2014
(Ref- IDMA Annual Publication 2015)
Name of Drug Indication Date of Approval
Hylan GF 20 injection 31-03-2008
SYNVAC ( Addl.Indn.)
For pain management in patients suffering from osteoarthiritis of the
knee ,hip, shoulder and ankle
Osteoarthritis of knee and hip
Contra-Indications:
Venous or lymphatic stasis of the leg Infected or severely inflammed joints Large joint effusions Intra-vascular , extra-vascular injection Injection into synovium capsule Hypersensitivity to avian protein infection skin disease or severe inflammation at inj site Special Precautions Reduce joint effusion prior to injection Pregnancy Lactation
Dosages/ Overdosage Etc:
For pain management in patients suffering from osteoarthiritis of the
knee ,hip, shoulder and ankle
Indication-
Osteoarthritis of knee and hip
Dosage-
Knee - 1x 2ml intra-articular injection of the knee joint at weekly intervals for 3 weeks Treatment may be repeated as necessary with minimum intervals of 4 weeks between courses
Max 6 inj inany 6 mths period Hip - 1x2ml initially single intra-articular injection of the hip If necessary administer second inj 3 mths later Not recommended for patients below 18 years
Manufacturer Details